Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes (2019) Toxicol Appl Pharmacol

August 16, 2019

Burnett SD, Blanchette AD, Grimm FA, House JS, Reif DM, Wright FA, Chiu WA,
Rusyn I. Population-based toxicity screening in human induced pluripotent stem
cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Aug 16;381:114711. doi:
10.1016/j.taap.2019.114711. [Epub ahead of print] PubMed PMID: 31425687.

https://www.ncbi.nlm.nih.gov/pubmed/31425687

Go Back

Posted in Publications

Tags david reif comptox gxe toxpi

News & Publications

#header_text h2#site_subheading a, #header_text h2#site_subheading{ color:#000000 } @media (min-width: 650px) { #header_text h2#site_subheading a, #header_text h2#site_subheading{ } }

Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes (2019) Toxicol Appl Pharmacol

Search News & Publications

News & Publications